High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study, Proffered paper (oral presentation) 187O

Tessa Gerjanne Steenbruggen, Lars Steggink, C.M. Seynaeve, JJM van der Hoeven, Maartje J. Hooning, A Jager, IR Konings, J.R. Kroep, WM Smit, V. C. G. Tjan-Heijnen, E van der Wall, AD Bins, SC Linn, M Schaapveld, FE van Leeuwen, Carolina Schröder, H van Tinteren, E. G. E. de Vries, G. S. Sonke, Jourik A. Gietema

Research output: Contribution to conferenceAbstractAcademic

Original languageEnglish
Publication statusPublished - 2018
EventEuropean Society for Medical Oncology 2018 meeting -
Duration: 19-Oct-201823-Oct-2018

Conference

ConferenceEuropean Society for Medical Oncology 2018 meeting
Period19/10/201823/10/2018

Cite this